Supernus (INDV) Operating Income (2024 - 2026)
Indivior Pharmaceuticals' Operating Income came in at $180 million for Q3 2026, up 318.6% from $43 million a year earlier and up 12.5% from the prior quarter.
Powered by 
Analysis
Supernus (INDV) Operating Income (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Indivior Pharmaceuticals reported Operating Income of $558 million, up 145.8% year-over-year; for FY2025, it came in at $262 million, up 589.5% from FY2024.
- Operating Income carries a four-year compound annual growth rate of 5.3% (FY2021 to FY2025).
- Going back by year, Operating Income was $38 million in FY2024, -$152 million in FY2023, -$77 million in FY2022 and $213 million in FY2021.
- The Q3 2026 figure represents the highest quarterly Operating Income in data going back to Q1 2024.
- Year-over-year, Operating Income has increased for five consecutive quarters, with growth averaging 105.9% over the last six quarters.
- Business Quant data shows INDV's Operating Income at $160 million (Q2 2026), $137 million (Q1 2026) and $81 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Supernus | 4.28 Bn | 3.38 Bn | 305.00 Mn | 180.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 180.00 Mn |
| Jun 30, 2026 | 160.00 Mn |
| Mar 31, 2026 | 137.00 Mn |
| Dec 31, 2025 | 81.00 Mn |
| Sep 30, 2025 | 43.00 Mn |
| Jun 30, 2025 | 72.00 Mn |
| Mar 31, 2025 | 66.00 Mn |
| Dec 31, 2024 | 46.00 Mn |
| Sep 30, 2024 | 35.00 Mn |
| Jun 30, 2024 | -118.00 Mn |
| Mar 31, 2024 | 75.00 Mn |
API Access
Supernus Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();